Under CopyrightWenzel, A.A.WenzelTeigeler, M.M.TeigelerSchäfers, C.C.Schäfers2022-03-0927.01.20042002https://publica.fraunhofer.de/handle/publica/34141010.24406/publica-fhg-341410Structure: - Testing strategy needed for substances with suspected endocrine disrupting activity (example: estrogenicity) - Different test designs under discussion: Fish full life cycle (population relevant effects); Short term tests (predictive?) - Comparison of effects in: Life cycle tests with Danio rerio: EE2, BPA, OP, GEN (life performance endpoints, vitellogenin, histology); 14 d exposure adult Danio rerio, BPA: vitellogenin; 14 d exposure juvenile Danio rerio, BPA: vitellogeninen570610620660From population relevant endpoints to biomarkerspresentation